The Risk Factors for Acute Radiation Pneumonitis in Patients With Prior Receipt of Immune Checkpoint Inhibitors

Prospective Study on Factors Predicting Chemo-Radiotherapy Induced Pulmonary and Esophageal Injury

NCT00631839 ·Status: UNKNOWN

Omitting Clinical Target Volume in Radical Treatment of Unresectable Stage III Non-small Cell Lung Cancer

NCT05909137 ·Status: NOT_YET_RECRUITING

Tumor Response in Hypofractionated Radiotherapy

NCT02854449 ·Status: UNKNOWN

Hypofractionated vs. Conventionally Fractionated Concurrent CRT for Unresectable Stage III NSCLC

NCT03331575 ·Status: UNKNOWN ·Phase: PHASE3

Immunotherapy SBRT Sensitization of the Programmed Death-1 (PD-1) Effect

NCT03825510 ·Status: COMPLETED ·Phase: PHASE2

Abscopal Effect of Radiation in Combination With rhGM-CSF for Metastatic Non-small Cell Lung Cancer

NCT03113851 ·Status: COMPLETED ·Phase: PHASE2

131I-L19SIP Radioimmunotherapy Combined With Radiochemotherapy in Patients With Locally-advanced Non Small Cell Lung Cancer (NSCLC)

NCT01124812 ·Status: TERMINATED ·Phase: PHASE1

Safety and Efficacy of SBRT in the Reirradiation for Ultra-central Thoracic Malignant Tumors

NCT05189054 ·Status: RECRUITING

Hypofractionated Radiotherapy Followed by Chemo-immunotherapy Induction Therapy

NCT06914050 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Dose-painting Radiation for LA-NSCLC

NCT05031533 ·Status: RECRUITING ·Phase: NA

Early Biomarkers of Tumor Response in High Dose Hypofractionated Radiotherapy Word Package 3 : Immune Response

NCT02439008 ·Status: TERMINATED ·Phase: NA

Combining ICI With SBRT or HypoFrx-RT for ES NSCLC

NCT05451173 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2

Anti-tumor Immune Response in Patients With Cancer Undergoing Radiation Therapy

NCT02310594 ·Status: TERMINATED

Predictors of Radiation Pneumonitis in Locally Advanced Lung Cancer Treated With Chemoradiation

NCT01580579 ·Status: COMPLETED

Radiation Pneumonitis After SBRT for NSCLC

NCT02428049 ·Status: ACTIVE_NOT_RECRUITING

Moderate Hypofractionated Radiotherapy for Lung Cancer

NCT03833193 ·Status: UNKNOWN ·Phase: NA

Clinical Benefit and Biomarker Analysis of Combination of PD-1/PD-L1 Immune Checkpoint Inhibitors and Radiotherapy

NCT04892849 ·Status: RECRUITING

Individualized Adaptive Radiotherapy Based on PET/CT and IMRT for Locally Advanced Non-Small Cell Lung Cancer (NSCLC)

NCT02790190 ·Status: UNKNOWN ·Phase: PHASE3

Biodistribution and Kinetics of 18F-AraG in Non-Small Cell Lung Cancer

NCT04052412 ·Status: UNKNOWN ·Phase: PHASE1

Survival Efficacy of Combined Radiotherapy and Immunotherapy in Patients With Metastatic Non-small Cell Lung Carcinoma

NCT07111104 ·Status: COMPLETED

Stereotactic Volumetric Radiotherapy in Prostate Cancer

NCT02423889 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety of Super-hyperfractionation Pulse Radiotherapy Combined With ICIs for Advanced NSCLC

NCT05754203 ·Status: RECRUITING ·Phase: NA

Phase IB/II Study of NRT Combined With Radiotherapy for Advanced HCC

NCT03199807 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

Stereotactic Radiotherapy With Different Fractionation Modes for the Early Lung Cancer

NCT05802641 ·Status: UNKNOWN

Prophylactic Cranial Irradiation in Erlotinib/Gefitinib-responders With Non-small Cell Lung Cancer (NSCLC) (RT1001)

NCT01158170 ·Status: UNKNOWN ·Phase: PHASE3